Clinical Trials Browser

Withdrawn × Astrocytoma × Clear all

NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT05341947 2025-10-22

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

Phase 1 Withdrawn

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma

NCT04838782 2025-07-08

Role of Repeat Resection in Recurrent Glioblastoma

Phase NA Withdrawn

Astrocytoma, Glioblastoma

NCT03956706 2023-03-15

Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas

Phase NA Withdrawn

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular

NCT03649464 2022-10-07

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Phase 1/2 Withdrawn

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT03353896 2020-12-10

NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma

Phase NA Withdrawn

Astrocytoma, Oligodendroglioma

NCT01117155 2019-12-12

A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive

NCT01212237 2019-07-29

Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

Astrocytoma, Brain Neoplasms, Glioma, Meningioma

NCT00645385 2019-06-04

Gliadel-MRS

Astrocytoma, Glioblastoma, Neoplasms, Oligodendroglioma

NCT02540135 2018-07-20

Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma

Phase NA Withdrawn

Astrocytoma, Glioblastoma, Glioma

NCT01740570 2018-01-19

Phase I/II Cabazitaxel for Recurrent Malignant Glioma

Phase 1/2 Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02977689 2017-12-20

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

Phase 2 Withdrawn

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT02194452 2017-04-28

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Phase NA Withdrawn

Familial ependymoma, Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroma, Acoustic, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Glioma, Subependymal, Gliosarcoma, Optic Nerve Glioma

NCT02976441 2017-02-20

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Phase EARLY_PHASE1 Withdrawn

Astrocytoma, Ependymoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

NCT00006263 2015-08-05

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

Phase 2 Withdrawn

Astrocytoma, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00433472 2015-07-29

MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806

Phase NA Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01861990 2015-05-22

Valproic Acid in Childhood Progressive Brain Tumors

Phase 1 Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT01711580 2015-05-12

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Astrocytoma, Glioblastoma, Glioma

NCT00458744 2014-08-08

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Phase 1 Withdrawn

CNSLymphoidOther hematologic neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Leukemia, Lymphoma, Medulloblastoma, Recurrence, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT02055196 2014-06-02

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Phase 1 Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

NCT00897858 2013-04-19

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Astrocytoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

NCT00734864 2012-11-21

Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Phase 1 Withdrawn

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00005083 2012-10-04

Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors

Phase 2 Withdrawn

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT00005790 2012-06-11

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Phase NA Withdrawn

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT00003564 2012-02-22

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Phase 3 Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00243490 2010-01-12

Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

Phase 2 Withdrawn

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma

NCT00226668 2008-01-03

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Phase 3 Withdrawn

Astrocytoma, Brain Edema, Brain Neoplasms, Edema